EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis

Xiaoyi Mo iD, Keyu Meng, Bohan Xu, Zehui Li, Shanwei Lan, Zhengda Ren, Xin Xiang, Peiqian Zou, Zesen Chen, Zhongming Lai, Xiang Ao, Zhongyuan Liu und 6 weitere

Proceedings of the National Academy of Sciences · 15.04.2025 · 122 (15)

DOI: 10.1073/pnas.2423991122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 07.04.2025. Verfasst von Xiaoyi Mo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Spine Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: NFATC Transcription Factors, Osteoclasts, Osteoporosis, Postmenopausal, Osteogenesis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation (China Postdoctoral Foundation Project).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased differentiation or activity of osteoclasts is the key pathogenic factor of postmenopausal osteoporosis (PMOP). N4‐acetylcytidine (ac4C) modification, catalyzed by Nat10, is a novel posttranscriptional mRNA modification related to many diseases. However, its impact on regulating osteoclast activation in PMOP remains uncertain. Here, we initially observed that Nat10-mediated ac4C positively correlates with osteoclast differentiation of monocytes and low bone mass in PMOP. The specific knockout of Nat10 in monocytes and remodelin, a Nat10 inhibitor, alleviates ovariectomized (OVX)-induced bone loss by downregulating osteoclast differentiation. Mechanistically, epitranscriptomic analyses reveal that the nuclear factor of activated T cells cytoplasmic 1 (Nfatc1) is the key downstream target of ac4C modification during osteoclast differentiation. Subsequently, translatomic results demonstrate that Nat10-mediated ac4C enhances the translation efficiency (TE) of Nfatc1, thereby inducing Nfatc1 expression and consequent osteoclast maturation. Cumulatively, these findings reveal the promotive role of Nat10 in osteoclast differentiation and PMOP from a novel field of RNA modifications and suggest that Nat10 can be a target of epigenetic therapy for preventing bone loss in PMOP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NFATC Transcription FactorsOsteoclastsOsteoporosis, PostmenopausalOsteogenesisCytidineFemaleAnimalsHumansMiceCell DifferentiationProtein BiosynthesisMice, Inbred C57BL

Stichwörter der Autor:innen

N4‐acetylcytidineNat10Nfatc1osteoporosis

Substanzen

NFATC Transcription FactorsCytidineNfatc1 protein, mouseNFATC1 protein, human

Autor:innen und Institutionen

  • Division of Spine Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and infectious Diseases, NIH, Bethesda, MD 20814.
  • Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong 999077, China.
  • The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518000, China.

ORCID-Profile: Xiaoyi Mo, Zhizhang Wang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province
  • China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)
  • President Foundation of Nanfang Hospital, Southern Medical University

Zitieren

APA

Mo, X., Meng, K., Xu, B., Li, Z., Lan, S., Ren, Z., Xiang, X., Zou, P., Chen, Z., Lai, Z., Ao, X., Liu, Z., Shang, W., Dai, B., Luo, L., Xu, J., Wang, Z., & Zhang, Z. (2025). Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis. Proceedings of the National Academy of Sciences, 122(15). https://doi.org/10.1073/pnas.2423991122

Vancouver

Mo X, Meng K, Xu B, Li Z, Lan S, Ren Z, et al. Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis. Proceedings of the National Academy of Sciences. 2025;122(15). doi:10.1073/pnas.2423991122

BibTeX
@article{Mo2025,
  author = {Mo, Xiaoyi and Meng, Keyu and Xu, Bohan and Li, Zehui and Lan, Shanwei and Ren, Zhengda and Xiang, Xin and Zou, Peiqian and Chen, Zesen and Lai, Zhongming and Ao, Xiang and Liu, Zhongyuan and Shang, Wanjing and Dai, Bingyang and Luo, Li and Xu, Jiajia and Wang, Zhizhang and Zhang, Zhongmin},
  title = {Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {15},
  doi = {10.1073/pnas.2423991122}
}
Kostenlos starten →